Depo-Provera, a widely used injectable contraceptive, has been a popular choice for millions of women worldwide seeking long-term birth control. However, there is a demonstrable link between the use of this contraceptive and bone density loss, which can lead to osteoporosis. This connection has prompted healthcare providers and patients alike to reevaluate the risks and benefits of this widely prescribed medication.
Does Depo-Provera Affect Bone Density?
Research has consistently shown that women using this contraceptive method experience a decrease in bone mineral density, especially during the first few years of use. This bone loss tends to slow down over time, eventually approaching the normal rate of age-related bone density decline. Young women in their teens and early twenties appear to be more susceptible to this bone-thinning effect.
The good news is that bone density tends to improve after stopping Depo-Provera, with levels often returning close to baseline after a few years. However, the loss of bone density can contribute to osteoporosis, a condition where bones become porous, fragile, and more susceptible to fractures. When the body breaks down more bone than it replaces, the weakened bone structure can lead to skeletal changes and increase the risk of broken bones.
Symptoms of Osteoporosis in Depo-Provera Patients
Osteoporosis does not usually show any symptoms in its early stages. Many people are unaware they have osteoporosis until they experience a fracture from a minor fall or accident that wouldn’t normally cause that level of harm.
While osteoporosis itself may not directly cause symptoms, some warning signs could indicate a loss of bone density:
- Lower back pain
- Unexplained height loss of an inch or more
- Changes in posture, such as stooping or bending forward more than usual
- Shortness of breath due to compressed disks in the spine, which can reduce lung capacity
Can You Pursue a Legal Claim After an Osteoporosis Diagnosis?
Some people have filed bone density lawsuits for Depo-Provera in the past. Previous claims alleged that Pfizer, the manufacturer of Depo-Provera, failed to adequately warn about the risk of decreased bone density leading to osteoporosis. In response to these concerns, Pfizer added a black box warning to Depo-Provera’s medication label in 2004, alerting users to the potential risk of bone density loss.
In Canada, a class action lawsuit was filed against Pfizer in May 2008. This lawsuit claimed that Pfizer misrepresented the risk of bone mineral density loss associated with Depo-Provera use. In September 2021, Pfizer settled these claims, paying $1,913,750 to the class and $262,500 to health insurance companies.
Currently, the focus of legal claims related to Depo-Provera has shifted. People are now pursuing claims after being diagnosed with brain tumors and meningioma, rather than osteoporosis-related issues. For assistance with a Depo-Provera brain tumor lawsuit, contact an attorney today.
Contact a Depo-Provera Lawsuit Attorney Today
Osteoporosis and other health conditions related to Depo-Provera use can have serious long-term consequences. If you are diagnosed with a brain tumor or meningioma after taking this medication, you may have grounds for legal action—and Shapiro Legal Group, PLLC can help you explore your options.
Our attorneys are well-versed in pharmaceutical litigation and will work diligently to hold Pfizer accountable for your losses. Contact us today at (800) 220-0984 to discuss your case and take your first steps toward justice.